epilepsy

Can folic acid mitigate autism risk for kids with epileptic mothers?A new study reveals that folic acid supplementation in mothers treated for epilepsy during pregnancy had children who were more likely to display autistic traits.
Cannabis-derived epilepsy drug on the horizonA pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
Small Doses: 6 Stories You Need to Know in January
Small Doses: 6 Stories You Need to Know in JanuaryEasy-to-swallow bits of information from around the world of pharmacy.
Two potential drugs to treat Dravet syndromePhase III clinical trials of new antiepileptic medications show promise for reducing frequency of convulsive seizures in children.
FDA approves generic Tamiflu, plus 2 other new drugs
FDA approves generic Tamiflu, plus 2 other new drugsFDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
Preeclampsia as a harbinger of longer-term cerebral damageA study looks at the long-term impact that preeclampsia can have on mothers' brains. Plus: A study examines the impact of maternal obesity on a child's risk of childhood epilepsy.
How one hospital reduced pediatric epilepsy emergency visits, admissionsNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.
FDA approves brivaracetam for use in partial onset seizure treatmentBrivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.
How physicians can guide seizure management in schoolsSeizures can be serious and scary in schools, but AAP guidelines say action plans outlining rescue medications and interventions can help.
FDA clears new treatment for epileptic seizuresFDA has approved brivaracetam (Briviact, UCB, Inc.) as an add-on therapy for the treatment of partial onset-seizures in patients with epilepsy.